Company Filing History:
1 out of 9 
1 out of 855 
1 out of 1 Years Active: 2017
Title: Surakameth Mahasirimongkol: Innovator in Risk Assessment for Drug Reactions
Introduction
Surakameth Mahasirimongkol is a notable inventor based in Nonthaburi, Thailand. He has made significant contributions to the field of pharmacogenetics, particularly in assessing the risk of cutaneous adverse drug reactions associated with antiretroviral agents.
Latest Patents
His most recent patent focuses on a method for predicting the risk of patients developing cutaneous adverse drug reactions to non-nucleoside reverse transcriptase inhibitors, such as nevirapine. This innovative approach utilizes the HLA-B*3505 allele and polymorphisms in the CCHCR1 gene to enhance patient safety and treatment efficacy.
Career Highlights
Surakameth has worked with prestigious institutions, including Mahidol University and Riken Corporation. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
He has collaborated with esteemed colleagues, including Somnuek Sungkanuparph and Sasisopin Kiertiburanakul, further enriching his research endeavors.
Conclusion
Surakameth Mahasirimongkol's innovative work in risk assessment for drug reactions exemplifies the importance of personalized medicine in improving patient outcomes. His contributions continue to influence the field significantly.